StockData

Cuprina Holdings (Cayman) vs Profusa

CUPR and PFSA side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CUPR and PFSA compare

Cuprina Holdings (Cayman) scores higher on the StockData Score (3 against 0 for Profusa), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCUPRPFSA
Size and price
Market cap–$53.7K
Share price$1.68$0.406
Change, 1 year−72.4%−100.0%
Beta (5Y)−0.143.11
Employees10–
StockData Score
Total score3 (better)0
Valuation score00
Growth score1 (better)0
Performance score00
Health score2 (better)0
Dividend score00
Growth
Revenue growth (TTM)3.3%–
Profitability
Gross margin−1.3%–
Operating margin−9680%–
Net margin−9367%–
FCF margin−18423%–
Return on equity−1569%–
Financial health
Debt / equity0.03–
Interest coverage−328.0×−136.6× (better)
Current ratio2.35 (better)0.03
Altman Z-score–−364.70
Piotroski F-score4 (better)3
Dividends and buybacks
Shareholder yield–0.00%
Ownership
Held by institutions0.00%25.3%
Insider net buying, 12 months–−$116K

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.